Allogene Therapeutics
Monique D. has a background in executive assisting and administrative work. In 2013, they worked as an Administrative Specialist at Bioseek, a Division of DiscoverX, for a period of three years. In 2017, they then worked as a Contract Executive Assistant to the CMO & CSO at UNITY Biotechnology for one year. Finally, in 2018, they began working at Allogene Therapeutics as an Executive Assistant to multiple VPs, including the CMO, CSO, VP Biometrics, VP Clinical Operations, and VP Global Regulatory Affairs.
Monique D. has a Bachelor of Business Administration (BBA) degree in Business Administration and Management, General from San Francisco State University.
This person is not in any teams
Allogene Therapeutics
1 followers
Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.